PARKHOSPSPark Medi World Ltd.

    Park Medi World Q2 FY27 Results: Consolidated Net Profit ₹54.46 Crore on Total Income of ₹521 Crore

    • Earnings
    • Healthcare services
    A long hospital corridor with cream walls, red stripes, closed doors and recessed ceiling lights.
    W.carter, via Wikimedia Commons (CC0). Illustrative image.

    Park Medi World reported consolidated total income of ₹520.65 crore and consolidated net profit of ₹54.46 crore for the quarter ended 30 Sep 2026, it said in a filing on 13 Nov 2026. Standalone total income was ₹38.22 crore and the standalone result was a net loss of ₹65.70 lakh.

    Key highlights

    Consolidated

    Including its subsidiaries

    • Total income: ₹520.65 crore, up 24.5% YoY and 7.7% QoQ
    • Net profit and EPS: ₹54.46 crore, down 30.8% YoY; basic EPS ₹1.26 against ₹2.05 a year earlier
    • Finance costs: ₹14.08 crore, down 3.2% YoY and up 43.5% QoQ

    Standalone

    The company on its own, without its subsidiaries

    • Total income: ₹38.22 crore, up 65.0% YoY and 0.1% QoQ
    • Net profit and EPS: Net loss of ₹65.70 lakh; basic EPS -₹0.02 against ₹0.22 a year earlier
    • Other income: ₹4.17 crore, 10.9% of total income, against ₹0.20 crore a year earlier

    Summary

    Consolidated ₹ crore
    ParticularsQ2 FY27Q2 FY26YoYQ1 FY27QoQ
    520.65418.22+24.5%483.36+7.7%
    54.4678.70-30.8%88.51-38.5%
    EPS, basic (₹)1.262.05-38.5%2.05-38.5%

    Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

    Total income grew faster than net profit. Revenue from operations rose 24.6% YoY to ₹511.03 crore, faster than other income, which rose 20.0% to ₹9.63 crore. Net profit fell 30.8% YoY to ₹54.46 crore, a larger decline than the 16.3% fall in profit before tax to ₹76.41 crore.

    Tax expense rose 74.0% YoY to ₹21.96 crore, which is 28.7% of profit before tax, against ₹12.62 crore a year earlier. Depreciation rose 40.1% YoY to ₹20.86 crore. Other income of ₹9.63 crore is 12.6% of profit before tax. Net profit attributable to owners of the parent is ₹52.19 crore, against ₹73.73 crore a year earlier. The statutory auditor, Agiwal & Associates, issued an unmodified limited review conclusion on the consolidated results, and exceptional items are nil for the quarter.

    The auditor did not review the interim results of 20 subsidiaries, whose total revenues for the quarter were ₹4,046.12 million, and the auditor's conclusion is based on the reports of other auditors for those subsidiaries.

    Standalone ₹ crore
    ParticularsQ2 FY27Q2 FY26YoYQ1 FY27QoQ
    38.2223.17+65.0%38.20+0.1%
    -0.664.90n/a1.08n/a
    EPS, basic (₹)-0.020.22n/a0.20n/a

    Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

    The standalone business reported a net loss of ₹65.70 lakh, against a net profit of ₹4.90 crore a year earlier. Total income rose 65.0% YoY to ₹38.22 crore, but profit before tax moved to a loss of ₹0.61 crore from a profit of ₹6.09 crore, and finance costs fell 47.7% to ₹1.72 crore.

    Depreciation rose to ₹4.36 crore from ₹1.16 crore a year earlier, and other income of ₹4.17 crore is 10.9% of total income, against ₹0.20 crore a year earlier. Standalone tax expense was ₹0.05 crore, against ₹1.20 crore a year earlier. Consolidated net profit of ₹54.46 crore is ₹55.12 crore higher than the standalone figure.

    Inference

    The filing says the IPO proceeds have been fully utilised as on 30 Sep 2026, with ₹380 crore allocated to repayment or prepayment of borrowings and ₹2,453.18 million to unidentified inorganic acquisitions and general corporate purposes. It says the V3 Healthcare acquisition of 80% stake cost approximately ₹162.84 crore, with the remaining 20% to be acquired by 30 Apr 2030, and that the Mehar Hospital stake is to be acquired by 3 Dec 2026.

    The company says the Income Tax search or survey from 12 Oct 2026 to 17 Oct 2026 has had no impact on its operations, commitments and expansion plans. The filing does not say why consolidated net profit and standalone profit fell against the year-earlier quarter, or what the outcome of the search will be.

    Filed with BSE on . Reference: Original filing (PDF)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Related posts

    All Park Medi World Ltd. articles